| 921 | JEMERSON, ANTHONY LATROYDURHAM, NC · 27709 | DIRECTOR, NATIONAL ACCTS, VIIV · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2026-09-04 | $15 | Primary (P) | Filing 2018012FEC filing ↗ |
| 922 | GROSS, APRIL DDURHAM, NC · 27709 | SR SALES SPEC, PHARMA · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2026-09-21 | $15 | Primary (P) | Filing 2018012FEC filing ↗ |
| 923 | BROWN, BRENT WILLIAM GEORGEDURHAM, NC · 27709 | SALES FORCE EFFECTIVENESS (ONCOLOGY) · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2026-09-21 | $15 | Primary (P) | Filing 2018012FEC filing ↗ |
| 924 | NEILSON, NICHOLAS JAMESDURHAM, NC · 27709 | PRICING/REIMBURSEMENT - NICHOLAS NEILS · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2026-09-21 | $15 | Primary (P) | Filing 2018012FEC filing ↗ |
| 925 | PAUL, MAUREEN ROSEDURHAM, NC · 27709 | CHANNEL ACCT DIR, MARKET ACCESS · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2026-09-21 | $15 | Primary (P) | Filing 2018012FEC filing ↗ |
| 926 | MONNIER, MICHELLE MPHILADELPHIA, PA · 19112 | SENIOR DIRECTOR, PUBLIC SEGMENT MARKET · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2026-09-21 | $15 | Primary (P) | Filing 2018012FEC filing ↗ |
| 927 | GREENGROVE, KATHRYN ANNEDURHAM, NC · 27701 | SR. DIRECTOR US PHARMA COMMERCIAL OPER · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2026-09-21 | $15 | Primary (P) | Filing 2018012FEC filing ↗ |
| 928 | GALLAGHER, RUSTINDURHAM, NC · 27709 | VACCINE STRATEGIC ACCT LEAD · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2026-09-04 | $15 | Primary (P) | Filing 2018012FEC filing ↗ |
| 929 | PAPANICKOLAS, YVONNE MARIEDURHAM, NC · 27709 | SR SALES SPEC, PHARMA · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2026-09-04 | $15 | Primary (P) | Filing 2018012FEC filing ↗ |
| 930 | UMALI, ROMUALDO LDURHAM, NC · 27709 | VACCINES SALES DIRECTOR · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2026-09-04 | $15 | Primary (P) | Filing 2018012FEC filing ↗ |
| 931 | PAUL, MAUREEN ROSEDURHAM, NC · 27709 | CHANNEL ACCT DIR, MARKET ACCESS · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2026-09-04 | $15 | Primary (P) | Filing 2018012FEC filing ↗ |
| 932 | CHAEL, ALEXANDERDURHAM, NC · 27709 | VACCINES ACCOUNT MANAGER · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2026-09-04 | $15 | Primary (P) | Filing 2018012FEC filing ↗ |
| 933 | PARKER, DEBRA D.DURHAM, NC · 27709 | RX ACCOUNT MANAGEMENT RESP BIOLOGICS · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2026-09-21 | $15 | Primary (P) | Filing 2018012FEC filing ↗ |
| 934 | NIJINSKY, SONYA ALEXANDRA MOIRAPHILADELPHIA, PA · 19112 | INTERNAL QUALITY AUDIT · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2026-09-21 | $15 | Primary (P) | Filing 2018012FEC filing ↗ |
| 935 | UMALI, ROMUALDO LDURHAM, NC · 27709 | VACCINES SALES DIRECTOR · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2026-09-21 | $15 | Primary (P) | Filing 2018012FEC filing ↗ |
| 936 | GRANDISON, REGINA FDURHAM, NC · 27701 | SALES AND/OR MARKETING TRAINING · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2026-09-21 | $15 | Primary (P) | Filing 2018012FEC filing ↗ |
| 937 | ANDERSON, CHARLES ALLENDURHAM, NC · 27709 | VACCINE KEY ACCT LEAD · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2026-09-04 | $15 | Primary (P) | Filing 2018012FEC filing ↗ |
| 938 | CRUZ, CHRISTIAN OMARWASHINGTON, DC · 20004 | PUBLIC POLICY · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2026-09-04 | $15 | Primary (P) | Filing 2018012FEC filing ↗ |
| 939 | GRANDISON, REGINA FDURHAM, NC · 27701 | SALES AND/OR MARKETING TRAINING · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2026-09-04 | $15 | Primary (P) | Filing 2018012FEC filing ↗ |
| 940 | O'NEILL, KELLY ANNMARIETTA, PA · 17547 | DISTRIBUTION · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2026-09-04 | $15 | Primary (P) | Filing 2018012FEC filing ↗ |